T
Touchlight Genetics
Develops a DNA production platform designed for the development of DNA vaccines for oncology and infectious diseases
At a glance
- Founded
- 2007
- Headquarters
- London, United Kingdom
- Sector
- Biotech & Life Sciences
- Outcome tier
- Unicorn$1–10B valuation tier
News
More headlines
Open roles
Touchlight Genetics in the London ecosystem
The Touchlight Genetics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- DVDowning Ventures
Series B and later3 investors entered at this stage
- BGBridford Group
- NONovator
- BIBridford Investments
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
15 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Touchlight Genetics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Touchlight Genetics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

